Summary

The AVIEW platform will analyse chest CT studies for lung-cancer screening and return structured findings inside INFINITT’s PACS, including nodule assessment and prior-image comparison. The companies described it as their second North American deployment and said the repeatable integration model is intended to expand to more hospitals.

Why it matters

Routine PACS integration is a stronger adoption signal than a standalone pilot because it places AI inside the workflow radiologists already use.

Sources